135 related articles for article (PubMed ID: 8953510)
1. Comparison of two binding equations for prediction of the concentration of unbound valproic acid in the serum of adult epileptic polytherapy patients.
Kodama Y; Kuranari M; Kodama H; Zaizen T; Yukawa E; Fujii I; Takeyama M
J Pharm Pharmacol; 1996 Oct; 48(10):1068-72. PubMed ID: 8953510
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
J Pharm Sci; 1995 Jul; 84(7):835-9. PubMed ID: 7562433
[TBL] [Abstract][Full Text] [Related]
4. Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Kodama Y; Kuranari M; Kodama H; Tsutsumi K; Fujii I; Takeyama M
J Clin Pharmacol; 1995 Oct; 35(10):995-1002. PubMed ID: 8568018
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of unbound serum carbamazepine and carbamazepine-10,11-epoxide concentration prediction methods in polytherapy adult patients with epilepsy.
Kodama Y; Kuranari M; Fujii I; Kodama H; Takeyama M
Am J Ther; 1996 Oct; 3(10):699-707. PubMed ID: 11862225
[TBL] [Abstract][Full Text] [Related]
6. Prediction of unbound serum valproic acid concentration by using in vivo binding parameters.
Kodama Y; Kuranari M; Tsutsumi K; Kimoto H; Fujii I; Takeyama M
Ther Drug Monit; 1992 Oct; 14(5):349-53. PubMed ID: 1448839
[TBL] [Abstract][Full Text] [Related]
7. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Binding Equation Method for Unbound Serum Concentration Prediction of Valproic Acid in Polytherapy Pediatric Patients with Epilepsy.
Kodama Y; Kuranari M; Kodama H; Ashikari Y; Fujii I; Takeyama M
Am J Ther; 1995 Feb; 2(2):106-111. PubMed ID: 11847536
[TBL] [Abstract][Full Text] [Related]
9. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of serum protein binding in epileptic children during sodium valproate maintenance therapy.
Yu HY
Ther Drug Monit; 1984; 6(4):414-23. PubMed ID: 6440321
[TBL] [Abstract][Full Text] [Related]
11. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy.
Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Fujimura A
J Clin Pharmacol; 1999 Oct; 39(10):1070-6. PubMed ID: 10516942
[TBL] [Abstract][Full Text] [Related]
12. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
13. Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice.
Wallenburg E; Klok B; de Jong K; de Maat M; van Erp N; Stalpers-Konijnenburg S; Essink G; van Luin M
Ther Drug Monit; 2017 Jun; 39(3):269-272. PubMed ID: 28437285
[TBL] [Abstract][Full Text] [Related]
14. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
Dutta S; Faught E; Limdi NA
J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
[TBL] [Abstract][Full Text] [Related]
15. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
[TBL] [Abstract][Full Text] [Related]
16. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
17. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
[TBL] [Abstract][Full Text] [Related]
18. Empirical approach for improved estimation of unbound serum concentrations of valproic acid in epileptic infants by considering their physical development.
Ueshima S; Aiba T; Sato T; Matsunaga H; Kurosaki Y; Ohtsuka Y; Sendo T
Biol Pharm Bull; 2011; 34(1):108-13. PubMed ID: 21212527
[TBL] [Abstract][Full Text] [Related]
19. Effect of unbound clearance on binding parameters of valproic acid to serum proteins.
Kodama Y; Tsutsumi K; Teraoka I; Fujii I; Takeyama M
J Clin Pharmacol; 1993 Feb; 33(2):130-5. PubMed ID: 8440760
[TBL] [Abstract][Full Text] [Related]
20. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y
J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
